Integrated Colorimetric CRISPR/Cas12a Detection of Double-Stranded DNA on Microfluidic Paper-Based Analytical Devices
Biosensors · 2026
DOI: 10.3390/bios16010032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2026. Verfasst von Zhiheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Devices and Intelligent Diagnosis (ID2) Laboratory, CUHKSZ-Boyalife Regenerative Medicine Engineering Joint Laboratory, School of Medicine…. Hauptthemen laut MEDLINE: Colorimetry, CRISPR-Cas Systems, Biosensing Techniques, DNA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, 2022 Natural Science Foundation of Guangdong Provincial Basic and Applied Basic Research Fund, Guangdong Peral River Talent Program.
Abstract (Originalsprache)
Early detection of high-risk human papillomavirus (HPV), particularly HPV16 E7, is critical for cervical cancer prevention. Here, we report a novel, portable, and instrument-free biosensing platform that integrates recombinase polymerase amplification (RPA) with CRISPR/Cas12a-mediated detection on a microfluidic paper-based analytical device (μPAD) for colorimetric, visual readout of double-stranded DNA (dsDNA). The μPAD features seven functional zones, including lyophilized RPA and CRISPR reagents, and immobilized streptavidin and anti-FAM antibodies for signal generation. Upon target recognition, Cas12a’s trans-cleavage activity releases biotinylated-FAM-labeled reporters that form a sandwich complex with gold nanoparticle (AuNP)-conjugated anti-FAM antibodies, producing a visible red signal at the test zone. The gray value of the colorimetric signal correlates linearly with target concentration, enabling the quantitative detection of HPV16 E7 dsDNA down to 100 pM within 60 min. The assay demonstrated high accuracy and reproducibility in spiked samples. By combining isothermal amplification, CRISPR specificity, and paper-based microfluidics, this platform offers a rapid, low-cost, and user-friendly solution for point-of-care HPV screening in resource-limited settings. This work advances the integration of CRISPR diagnostics with μPAD, paving the way for scalable point-of-care molecular diagnostics beyond HPV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrated Devices and Intelligent Diagnosis (ID2) Laboratory, CUHKSZ-Boyalife Regenerative Medicine Engineering Joint Laboratory, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
ORCID-Profile: Guozhen Liu
Förderung
- National Natural Science Foundation of China
- 2022 Natural Science Foundation of Guangdong Provincial Basic and Applied Basic Research Fund
- Guangdong Peral River Talent Program
- Shenzhen Bay Open Laboratory Fund 2021 by the Shenzhen Bay Laboratory
- CUHKSZ-Boyalife Joint Laboratory Fund, and the University Development Fund
Zitieren
APA
Zhang, Z., Fu, Q., Wen, T., Zheng, Y., Ma, Y., Liu, S., & Liu, G. (2026). Integrated Colorimetric CRISPR/Cas12a Detection of Double-Stranded DNA on Microfluidic Paper-Based Analytical Devices. Biosensors. https://doi.org/10.3390/bios16010032
Vancouver
Zhang Z, Fu Q, Wen T, Zheng Y, Ma Y, Liu S, et al. Integrated Colorimetric CRISPR/Cas12a Detection of Double-Stranded DNA on Microfluidic Paper-Based Analytical Devices. Biosensors. 2026. doi:10.3390/bios16010032
BibTeX
@article{Zhang2026,
author = {Zhang, Zhiheng and Fu, Qiyu and Wen, Tiantai and Zheng, Youmin and Ma, Yincong and Liu, Shixian and Liu, Guozhen},
title = {Integrated Colorimetric CRISPR/Cas12a Detection of Double-Stranded DNA on Microfluidic Paper-Based Analytical Devices},
journal = {Biosensors},
year = {2026},
doi = {10.3390/bios16010032}
}
EUVIMED